Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study
Detection Principle
ImmunoAssay-Antibody
Target
IgM, IgG
Testing Method Category
Testing Method
kit (LFIA)
Testing Method - Additional Info
AllTest COVID-19 IgG/IgM
Reported Performance
Specificity: 100%; Sensitivity: 64.4% (overall), 88% (14 dpo)
Sample Size
90 positive & 100 negative samples
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements